Skip to main content

Table 2 Risk factors for TB incidence after IPT (intention-to-treat)

From: The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study

Total

 

n (%)

pyrs

TB

HR (95 % CI) a

P value

aHR (95 % CI) a,f

P value

Sex

Male

16,704 (95.8)

23,036

523

1

0.08

1

0.73

 

Female

741 (4.2)

999

18

0.67 (0.42–1.08)

 

1.09 (0.67–1.80)

 

Age, years b

≤29

2,370 (13.6)

3,221

30

1

<0.001

1

<0.001

 

30–39

4,677 (26.8)

6,660

131

2.13 (1.43–3.17)

 

2.18 (1.46–3.25)

 
 

40–49

7,363 (42.2)

10,291

276

2.81 (1.92–4.10)

 

2.84 (1.92–4.18)

 
 

≥50

3,035 (17.4)

3,863

104

2.69 (1.79–4.06)

 

2.77 (1.81–4.23)

 

Country of origin

South Africa

10,008 (57.4)

13,729

284

1

0.001

1

0.09

 

Lesotho

4,736 (27.2)

6,471

190

1.40 (1.17–1.68)

 

1.15 (0.95–1.40)

 
 

Mozambique

1,777 (10.2)

2,499

40

0.84 (0.60–1.18)

 

0.79 (0.57–1.11)

 
 

Other

917 (5.3)

1,327

27

1.06 (0.71–1.58)

 

0.82 (0.54–1.24)

 

Years in workforce c

0–9

4,683 (26.9)

6,391

85

1

<0.001

  
 

10–19

4,753 (27.3)

6,856

147

1.68 (1.28–2.20)

   
 

20–29

5,511 (31.7)

7,608

217

2.11 (1.64–2.71)

   
 

≥30

2,446 (14.1)

3,107

90

2.12 (1.57–2.86)

   

Type of work

Surface

1,537 (8.8)

2,165

30

1

0.002

1

0.002

 

Underground

15,836 (91.2)

21,762

508

1.71 (1.18–2.48)

 

1.75 (1.20–2.54)

 

Type of housing

Hostel

10,239 (58.7)

14,378

364

1

<0.001

1

0.004

 

Other

7,206 (41.3)

9,657

177

0.67 (0.55–0.80)

 

0.74 (0.61–0.91)

 

Previous TB

No

15,427 (88.5)

21,413

430

1

<0.001

1

<0.001

 

Yes

2,005 (11.5)

2,605

111

2.08 (1.69–2.57)

 

1.89 (1.52–2.35)

 

Self-reported ART use

No

16,956 (97.3)

23,386

523

1

0.42

1

0.64

 

Yes

471 (2.7)

625

17

1.23 (0.76–1.99)

 

0.89 (0.54–1.46)

 

Number of

1–2

4,640 (26.6)

6,513

159

1

0.001

1

<0.001

IPT prescriptions d,e

3–5

1,855 (10.6)

2,557

56

0.86 (0.64–1.17)

 

0.81 (0.59–1.09)

 
 

6+

10,951 (62.8)

14,967

326

0.79 (0.65–0.97)

 

0.63 (0.51–0.77)

 
  1. a Adjusted for cluster using a fixed effect
  2. b P value for departure from linearity 0.002
  3. c P value for departure from linearity 0.02
  4. d P value for departure from linearity 0.83
  5. e P value for linear trend 0.02
  6. f On 17,332 participants, adjusted for all variables shown
  7. aHR, Adjusted hazard ratio; ART, Antiretroviral therapy; CI, Confidence interval; HR, Hazard ratio; IPT, Isoniazid preventive therapy; pyrs, Person-years; TB, Tuberculosis